Research Type: Business and Popular Press

Our expertise and opinions regarding drug pricing and development are sought by journalists for both Business and Popular Press. Our editorial writings, often in collaboration with other experts, allows us to comment in a broader forum.

  • High Prices Continue to Limit Access to Hepatitis C Treatment

  • Louisiana Revisits an Old Law to Address Drug Pricing

  • Drug Coupons: Helping a Few at the Expense of Everyone

  • Value Tools at ASCO 2016: Building a Framework for Prime Time

  • Bill to Kill CMS Drug Demo Gets Congressional Hearing

  • The Insurance Companies’ Latest Target: Specialty Drugs

  • Drug Companies Boosted Their Prices, Analysis Finds

  • This Rule Could Change How Doctors Profit from Using the Most Expensive Drugs

  • Exclusive: Makers Took Big Price Increases on Widely Used U.S. drugs

  • Medicare Tries an Experiment to Fight Perverse Incentives